Navigation Links
VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
Date:1/7/2008

- Comprehensive Phase 2 Program to Provide Initial Proof-of-Concept Data

This Year -

SAN FRANCISCO, Jan. 7 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that it has enrolled the first patient in its Phase 2 clinical trial that utilizes Positron Emission Tomography with fluorodeoxyglucose tracer (FDG-PET) to measure VIA-2291's ability to reduce vascular inflammation in treated patients. The company also provided a comprehensive update of its VIA-2291 Phase 2 clinical program.

VIA-2291 is a potent small molecule drug that targets inflammation in the blood vessel wall, a primary disease process in atherosclerosis. It is being developed as a once-daily, oral drug to potentially decrease the risk of major adverse cardiovascular events associated with inflammation, including heart attack and stroke. The FDG-PET trial is one of three concurrent, ongoing Phase 2 trials testing VIA-2291 in a variety of clinical settings. The Phase 2 clinical program's innovative trial designs are intended to provide new visibility to the role of inflammation in cardiovascular disease and the potential of VIA-2291 to address vascular inflammation.

"The continued momentum in our Phase 2 clinical program and the robustness of the trial designs put us on track to deliver critical proof-of-concept data for VIA-2291 later this year," said Lawrence K. Cohen, PhD, chief executive officer of VIA Pharmaceuticals. "Inflammation is the root cause of cardiovascular disease and there remains a significant unmet need to address the major adverse events, including heart attack and stroke,
'/>"/>

SOURCE VIA Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)...  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today ... and update at the Piper Jaffray 26 th Annual ... Eastern Time (5:30 a.m. Pacific Time), at The New York ... A live audio webcast of the presentation will be ... www.arenapharm.com . A replay of the presentation will be ...
(Date:11/24/2014)... , Nov. 24, 2014 /PRNewswire/ - Milestone Pharmaceuticals, ... trial conducted in Melbourne, Australia ... for the potential treatment of paroxysmal supraventricular tachycardia ... of MSP-2017 was well tolerated at single doses ... excellent safety profile, desirable PK properties including rapid ...
(Date:11/24/2014)... , Nov. 24, 2014  Marta Rendon, MD, founder ... Boca Raton , FL and international key opinion leader ... from the United States to attend ... Istanbul, Turkey . Here, at this gathering of ... as world renowned facial plastic surgery experts from ...
Breaking Medicine Technology:Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3
... DIEGO, Nov. 18 Rules-Based Medicine, Inc. (RBM) today announced ... with Covance Inc. (NYSE: CVD ) that will ... biomarker technologies and services for use in drug development. Under ... exclusive third-party provider of multiplexed protein biomarker testing services, and ...
... , , TEMECULA, Calif., Nov. 17 ... announced third quarter 2009 results. , "We are continuing ... increases in our gross margins," stated Steven H. Kane, ... third quarter revenues from sales of safety sponges were ...
Cached Medicine Technology:Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. 2Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. 3Patient Safety Technologies Reports Third Quarter Results 2Patient Safety Technologies Reports Third Quarter Results 3Patient Safety Technologies Reports Third Quarter Results 4Patient Safety Technologies Reports Third Quarter Results 5Patient Safety Technologies Reports Third Quarter Results 6
(Date:11/26/2014)... OR (PRWEB) November 26, 2014 The ... fresh water shortages, is moving forward with a plan ... drinking water.* Radio host Sharon Kleyne supports the San ... “Total Water Management” (TWM). According to Kleyne, by recycling ... constantly import new water could be greatly reduced. (Spagat, ...
(Date:11/26/2014)... Loffler Companies has been selected as ... an online information and news publication for resellers of ... consecutive year Loffler has earned this prestigious award and ... Dealer Awards honor the best and the brightest in ... honorees were chosen for their innovative marketing and sales ...
(Date:11/26/2014)... WOODLAND HILLS, CA (PRWEB) November 26, 2014 ... implants costing thousands of dollars, the prosthodontists at the Anacapa ... that paying for dental procedures can be daunting for some. ... to pay for the procedures they offer. , “No dentist ... functioning and beautiful set of teeth,” said Dr. Mamaly Reshad, ...
(Date:11/26/2014)... Senior Planning Services, providing “expert guidance for ... providing the adult demographic education and access to ... the rough seas of applying for Medicaid. Part of ... topic of Medicaid eligibility and proper planning, while also ... for this coverage. , Senior Planning Services has ...
(Date:11/26/2014)... ISI Telemanagement Solutions, Inc., a ... award the 2014 Lync Pioneer Award ... as a great honor to ISI, who continues ... Specifically, ISI offers an integrated collaboration reporting and ... including voice, video, Lync IM, and conferencing. ...
Breaking Medicine News(10 mins):Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 2Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 4Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 5Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2
... French and Spanish . , Researchers from ... belonging to the Laboratorio de Ciencias de la Visin y Aplicaciones, ... the tool required to implement it, which has been named "halometer". ... and a computer where the mouse is used as a response ...
... the old journalistic adage goes. Not necessarily, say researchers from ... of the Jewish General Hospital. In a first-of-its kind study ... versus 20 years ago, positivity and hope seem to be ... potential impact on patient perspectives," said Dr. Melissa Henry, the ...
... Epidemiology Unit, Southampton, UK, and Dr. Michal Hiligsmann ... with the ESCEO Young Investigator Awards, supported by a ... European Congress on Osteoporosis & Osteoarthritis (ECCEO11-IOF) now taking ... 2,500, recognize young investigators for their excellence in bone ...
... March 23, 2011 Although acupuncture is commonly used ... remain. Investigators from the Universities of Exeter & Plymouth ... (Daejeon, South Korea) critically evaluated systematic reviews of acupuncture ... this question. Reporting in the April 2011 issue of ...
... with Sichuan University in Chengdu, China, investigated eye movements in ... mechanisms that control them and how they compare between different ... movement, that is rare in British people, is much more ... differences in brain function between different populations. ...
... By Amanda Gardner HealthDay Reporter , ... developed a new way of predicting when breast cancer ... "epigenetic signatures" seem to distinguish more aggressive cancers from ... Epigenetic alterations do not involve changes to the ...
Cached Medicine News:Health News:Researchers develop a halometer that tests alterations in night vision 2Health News:Researchers develop a halometer that tests alterations in night vision 3Health News:Good news! Hope makes headlines 2Health News:Acupuncture for pain no better than placebo and not without harm 2Health News:Eye movement differs in British and Chinese populations 2Health News:Genes' 'On/Off' Switches Yield Clues to Breast Cancer 2Health News:Genes' 'On/Off' Switches Yield Clues to Breast Cancer 3
... Our variable volume Finnpipette ... in a high performance pipette. ... colour-coded volume range, ensures quality, ... identification of the volume range ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... Product features: Eppendorf "pipette/tip" system ensures ...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
Medicine Products: